Company

Congruence Therapeutics

Biotechnology Research Ca 41 employees

Employees: 41
Contacts: 2
Emails: 2

congruencetx.com LinkedIn Crunchbase

Congruence Therapeutics Overview

Headquarters: Ca
Website: congruencetx.com
Industry: Biotechnology Research
Employees: 41
Founded: 2021
Funding: 5.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

biotechnology computational chemistry machine learning protein misfolding

About Congruence Therapeutics

Congruence is a computationally-driven biotechnology company building a unique pipeline of transformative small molecule correctors rationally designed to rescue aberrant protein function. Our proprietary scalable platform, Revenir™, captures the biophysical features of proteins across their conformational ensembles, in order to identify novel allosteric and cryptic pockets which are virtually screened to generate novel chemical matter.

Congruence Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage

Congruence Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Michael-Rock Goldsmith, Ph.d.	Co-founder & Chief Innovation Scientist at Congruence Therapeutics Inc.	Durham, North Carolina, United States	Email
Tom Transue		Durham, North Carolina, United States	Email
Nancy Harrison	Venture Partner at Amplitude Ventures		View
Didier Leconte	Investor - Board Member - Strategic Connector - Leader - Ecosystem Builder - Mentor		View